Lev Facher covers the U.S. addiction and overdose crisis. The White House on Thursday unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic, pledging to align ...
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...
Gina Roberts used to have this recurring nightmare: frantic and broke, she would search everywhere for a drink, but always the alcohol would remain out of reach. The dream would trigger such ...
First-person stories of drug addiction, hope, healing, and recovery. Addiction is a complex and often misunderstood condition. This gripping special provides raw, unfiltered access to first-person ...
On her first day of Intro to Psychology in 2012, Mia* struck up a conversation with a fellow freshman named Jack. The two formed a friendship and then a relationship. Eventually, they got married.
There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...
The National Center on Addiction and Substance Abuse at Columbia University is a science-based, multidisciplinary organization focused on transforming society's understanding of and response to the ...
What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results